<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: biotech company</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Bionic eye maker has vision of the future</title>
   	 <description>Robert Greenberg got tired of hearing from senior engineers that it wasn't possible to build his product idea: a bionic eye that gives sight to the blind. &quot;A lot of the folks straight out of school didn't know any better, so I hired them instead,&quot; quipped Greenberg, chief executive of Second Sight Medical Products Inc., a Sylmar, Calif., biotech company. &quot;They didn't know how hard it was going to be, that it was impossible. And so they tried.&quot;</description>
     <link>http://medicalxpress.com/news/2013-05-bionic-eye-maker-vision-future.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 06 May 2013 19:40:01 EST</pubDate>
	 <guid isPermaLink="false">news287083791</guid>
	 
</item>
<item>
     <title>First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment</title>
   	 <description>A study led by Dr Josep Tabernero, the Director of Clinical Research at the Vall d'Hebron Institute of Oncology (VHIO) and Head of the Medical Oncology Department at the Vall d'Hebron University Hospital, shows for the first time that ribonucleic acid interference (RNAi) is effective in the treatment of cancer patients. Harnessing these molecules to silence genes involved in the development and growth of cancer cells is an important step forward in developing a new and more targeted type of cancer therapy.</description>
     <link>http://medicalxpress.com/news/2013-02-first-in-man-therapeutic-effect-rnai-gene.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 11 Feb 2013 08:46:49 EST</pubDate>
	 <guid isPermaLink="false">news279794788</guid>
	 
</item>
<item>
     <title>Spanish researchers design biomarkers for the detection of dengue and West Nile virus</title>
   	 <description>Researchers at the University of Granada have designed a set of biomarkers that can be used in diagnostic tests for the detection of dengue and the West Nile virus, two infectious diseases transmitted by the bite of a mosquito. These biomarkers can be used to identify these viral diseases, which affect millions of people worldwide.</description>
     <link>http://medicalxpress.com/news/2013-02-spanish-biomarkers-dengue-west-nile.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 06 Feb 2013 10:02:28 EST</pubDate>
	 <guid isPermaLink="false">news279367336</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/spanishresea.jpg" width="90" height="90" />
</item>
<item>
     <title>Amgen buying deCODE Genetics for $415 million</title>
   	 <description>Biotech pioneer Amgen Inc., in a bid for a big edge in using people's genetic information to find better ways to attack diseases, is buying human genetics research and analytics leader deCODE Genetics for $415 million.</description>
     <link>http://medicalxpress.com/news/2012-12-amgen-decode-genetics-million.html</link>
	 <category>Genetics</category>
	 <pubDate>Mon, 10 Dec 2012 13:41:16 EST</pubDate>
	 <guid isPermaLink="false">news274369261</guid>
	 
</item>
<item>
     <title>First trial in humans of 'minicells': A completely new way of delivering anti-cancer drugs</title>
   	 <description>A completely new way of delivering anti-cancer drugs to tumours, using 'minicells' derived from bacteria, has been tested for the first time in humans and found to be safe, well-tolerated and even induced stable disease in patients with advanced, incurable cancers with no treatment options remaining.</description>
     <link>http://medicalxpress.com/news/2012-11-trial-humans-minicells-anti-cancer-drugs.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 08 Nov 2012 18:00:03 EST</pubDate>
	 <guid isPermaLink="false">news271613615</guid>
	 
</item>
<item>
     <title>First gene therapy to go on sale in Europe in 2013</title>
   	 <description>Dutch biotech company uniQure said Monday it would start selling the first human gene therapy to be approved in the West by mid-2013 and predicted an explosion of similar therapies to come.</description>
     <link>http://medicalxpress.com/news/2012-11-gene-therapy-sale-europe.html</link>
	 <category>Genetics</category>
	 <pubDate>Mon, 05 Nov 2012 13:40:01 EST</pubDate>
	 <guid isPermaLink="false">news271343570</guid>
	 
</item>
<item>
     <title>New drug could treat Alzheimer's, multiple sclerosis and brain injury</title>
   	 <description>A new class of drug developed at Northwestern University Feinberg School of Medicine shows early promise of being a one-size-fits-all therapy for Alzheimer's disease, Parkinson's disease, multiple sclerosis and traumatic brain injury by reducing inflammation in the brain.</description>
     <link>http://medicalxpress.com/news/2012-07-drug-alzheimer-multiple-sclerosis-brain.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Tue, 24 Jul 2012 17:09:11 EST</pubDate>
	 <guid isPermaLink="false">news262368535</guid>
	 
</item>
<item>
     <title>Capability of curry component to treat disease merits US patent</title>
   	 <description>A U.S patent issued today to the University of Rochester and two other entities for the use of compounds related to a popular spice in the fight against cancer, acne, baldness, and other medical conditions.</description>
     <link>http://medicalxpress.com/news/2012-06-capability-curry-component-disease-merits.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 12 Jun 2012 12:42:32 EST</pubDate>
	 <guid isPermaLink="false">news258723742</guid>
	 
</item>
<item>
     <title>'Intelligent medicine' erases side effects</title>
   	 <description>Scientists at Aarhus University, Denmark in collaboration with the biotech company Cytoguide now publish a key to use glucocorticoid steroids in a kind of intelligent medicine that specifically hits the relevant cells. Data are based on rodent studies but if this principle is translated to humans it may greatly improve todays hazardous treatment with this type of potent steroids.</description>
     <link>http://medicalxpress.com/news/2012-05-intelligent-medicine-erases-side-effects.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 31 May 2012 11:30:01 EST</pubDate>
	 <guid isPermaLink="false">news257681451</guid>
	 
</item>
<item>
     <title>Scientists identify gene crucial to normal development of lungs and brain</title>
   	 <description>Scientists at the Salk Institute for Biological Studies have identified a gene that tells cells to develop multiple cilia, tiny hair-like structures that move fluids through the lungs and brain. The finding may help scientists generate new therapies that use stem cells to replace damaged tissues in the lung and other organs.</description>
     <link>http://medicalxpress.com/news/2012-01-scientists-gene-crucial-lungs-brain.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 12 Jan 2012 09:13:05 EST</pubDate>
	 <guid isPermaLink="false">news245581965</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/scientistsid.jpg" width="90" height="90" />
</item>
<item>
     <title>NJIT receives patent for new shunt to aid brain-injured patients</title>
   	 <description>NJIT Professor Gordon Thomas and NJIT Research Professor Reginald Farrow, both in the department of physics, and NJIT alumnus Sheng Liu, formerly a doctoral student of both researchers and now an engineer at a biotech company, were awarded a patent today for the NJIT SmartShunt, a unique device to help patients with brain injuries.</description>
     <link>http://medicalxpress.com/news/2012-01-njit-patent-shunt-aid-brain-injured.html</link>
	 <category>Other</category>
	 <pubDate>Tue, 03 Jan 2012 16:22:27 EST</pubDate>
	 <guid isPermaLink="false">news244830136</guid>
	 
</item>


</channel>
</rss>
